Pacira BioSciences
PCRX
PCRX
233 hedge funds and large institutions have $941M invested in Pacira BioSciences in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 78 increasing their positions, 79 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 239 → 233 (-6)
3.03% less ownership
Funds ownership: 111.16% → 108.12% (-3%)
10% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 40
Holders
233
Holding in Top 10
1
Calls
$19.8M
Puts
$2.49M
Top Buyers
| 1 | +$22.3M | |
| 2 | +$20.3M | |
| 3 | +$16.6M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$8.56M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$8.18M |
Top Sellers
| 1 | -$32M | |
| 2 | -$12.9M | |
| 3 | -$9.52M | |
| 4 |
Morgan Stanley
New York
|
-$9.25M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$9.09M |